U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. FDA | United States Pharmacopeia (USP) Asia-Pacific Economic Cooperation (APEC) Medical Product Supply Chain Dialogue - 04/25/2023
  1. News & Events for Human Drugs

Workshop | Mixed

Event Title
FDA | United States Pharmacopeia (USP) Asia-Pacific Economic Cooperation (APEC) Medical Product Supply Chain Dialogue
April 25 - 26, 2023


Date:
April 25 - 26, 2023
Day1:
- ET
Day2:
- ET
Location:
Event Location
Attend Online or
USP Rockville

12601 Twinbrook Parkway
Rockville, MD 20852
United States



Agenda

FDA and United States Pharmacopeia (USP) are cosponsoring the Asia-Pacific Economic Cooperation (APEC) Medical Product Supply Chain Dialogue. This program aims to accelerate APEC and global efforts to strengthen the resilience of global medical product supply chains. This meeting will bring international medical product regulators, multilateral organization representatives, and industry and academic professionals together, to discuss public health priorities, the impact of the COVID-19 pandemic on supply chains, and why the APEC Supply Chain Security Toolkit continues to be a valuable tool to stakeholders.

This event is open to the public and free of cost.

Topics will include:

  • APEC Roadmap to promote global medical product quality and supply chain security
  • Identifying vulnerabilities in the upstream supply chain
  • Mitigating and managing risks in raw material quality and supply chain security
  • Manufacturing solutions to strengthen global supply chain resilience
  • Experiences strengthening quality assurance in the Asia Pacific
  • Safeguarding patients from impurities in the drug supply chain
  • The supply chain imperative to fight AMR
  • Securing the downstream supply chain - good distribution practices & post-marketing surveillance
  • Securing the downstream supply chain - internet pharmacies

Confirmed FDA Speakers

Mark Abdoo

Associate Commissioner for Global Policy and Strategy 

Office of Global Policy and Strategy | Office of Policy, Legislation, and International Affairs | Office of the Commissioner | FDA

S. Leigh Verbois, PhD

Director

Office of Drug Security, Integrity, and Response | Office of Compliance | Center for Drug Evaluation and Research (CDER) | FDA

Sangeeta Chatterjee, PharmD

Deputy Director

Office of Drug Security, Integrity, and Response | Office of Compliance | Center for Drug Evaluation and Research (CDER) | FDA

Contact

For questions, please email RFD@USP.org.

Additional Information

 
Back to Top